Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20249| Title: | Readressing the rationale of irradiation in Stage I seminoma guidelines: A critical essay. | Austin Authors: | Berghen, Charlien;Albersen, Maarten;Blanchard, Pierre;Bossi, Alberto;Briganti, Alberto;Cozzarini, Cesare;Decaestecker, Karel;Fonteyne, Valérie;Haustermans, Karin;Joniau, Steven;Lim Joon, Daryl ;Khoo, Vincent;Nguyen, Paul L;Ost, Piet;Villeirs, Geert;Vulsteke, Christof;Zietman, Anthony;De Meerleer, Gert | Affiliation: | Department of Radiation Oncology, Leuven University Hospital, Leuven, Belgium Olivia Newton-John Cancer Wellness and Research Centre Department of Urology, Leuven University Hospital, Leuven, Belgium Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France Department of Urology, San Raffaele Hospital, Milan, Italy Department of Radiation Oncology, San Raffaele Hospital, Milan, Italy Department of Urology, Ghent University Hospital, Ghent, Belgium Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium Royal Marsden NHS Foundation Trust, London, United Kingdom Department of Radiation Oncology, Dana-Farber Cancer Institute, Bringham Women's Hospital, Boston, Massachusetts, United States of America Department of Radiology, Ghent University Hospital, Ghent, Belgium Department of Oncology, Ghent Maria Middelares Hospital, Ghent, Belgium Department of Molecular Imaging, Pathology, Radiotherapy& Oncology (MIPRO) Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America |
Issue Date: | 2019 | Date: | 2019-01-25 | Publication information: | BJU International 2019; 124(1): 35-39 | Abstract: | Germ cell tumors (GCT), accounting for 95% of malignant testicular tumors, can be divided into two groups: seminoma (SGCT) and non-seminoma (NSGCT). Seminomas typically arise in men in the fourth decade of life, compromising 60% of the GCT. At diagnosis, approximately 75% present with local disease (Stage I); 15% is detected with metastatic regional lymph nodes (Stage II) and 5-10% present with juxtaregional or visceral metastasis (Stage III) . This article is protected by copyright. All rights reserved. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/20249 | DOI: | 10.1111/bju.14686 | ORCID: | 0000-0003-4785-3409 0000-0002-2203-4848 0000-0002-1947-9694 0000-0001-9661-1436 |
Journal: | BJU International | PubMed URL: | 30680874 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.